الفهرس 
INTRODUCTIONOnly 14 pages are availabe for public view
 |  | from | 172 |  |  |
| | | from | 172 | | |
Abstract
Conclusion and Recommendations In our study it was shown that urotensinII an independant noninvasive predictor of the severity of the rheumatic valvular heart disease and left ventricular functions. UrotensinII is clearly reliable plasma biomarkers that could establish the severity of RVD and can guide the therapeutic approach and predict high risk patients for complications. We recommended another study involving a large number of patients